Characterization of caspase proteases in cytokine-dependent myeloid progenitor cells using enzyme affinity labeling

Journal of Cellular Biochemistry

Volumn 73, Issue 1, 1999, Pages 79-89

  Cho, Richard L ^a,b   Johnson, Daniel E ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Caspase; Cytokine; Myeloid; Protease

Indexed keywords

CASPASE; CASPASE 3; INTERLEUKIN 3; PROTEINASE;

AFFINITY LABELING; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; ENZYME ACTIVATION; ENZYME ASSAY; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN ANALYSIS;

AFFINITY LABELS; ANIMALS; CASPASE 3; CASPASES; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; MICE; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033120520     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990401)73:1<79::AID-JCB9>3.0.CO;2-R     Document Type: Article

References (58)

1. Alam A, Braun MY, Hartgers F, Lesage S, Cohen L, Hupo P, Denis F, Sekaly RP. 1997. Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus. J Exp Med 186:1503-1512.
2. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. 1996. Human ICE/ CED-3 protease nomenclature. Cell 87:171.
3. Antoku K, Liu Z, Johnson DE. 1997. Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents. Leukemia 11:1665-1672.
4. Antoku K, Liu Z, Johnson DE. 1998. IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells. Leukemia 12:682-689.
5. Arai KI, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. 1990. Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783-836.
6. Armstrong RC, Aja T, Xiang J, Gaur S, Krebs JF, Hoang K, Bai X, Korsmeyer SJ, Karanewsky DS, Fritz LC, Tomaselli KJ. 1996. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 271:16850-16855.
7. Barge RMY, Willemze R, Vandenabeele P, Fiers W, Beyaert R. 1997. Differential involvement of caspases in apoptosis of myeloid leukemic cells induced by chemotherapy versus growth factor withdrawal. FEBS Lett 409:207-210.
8. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. 1995. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891-893.
9. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG, Dixit VM. 1996. Molecular ordering of the cell death pathway. J Biol Chem 271:4573-4576.
10. Cohen GM. 1997. Caspases: The executioners of apoptosis. Biochem J 326:1-16.
11. Colatta F, Re F, Polentarutti N, Sozzani S, Mantovani A. 1992. Modulation of granulocyte survival by cytokines and bacterial products. Blood 80:2012-2020.
12. Datta R, Banach D, Kojima H, Talanian RV, Alnemri ES, Wong WW, Kufe DW. 1996. Activation of the CPP32 protease in apoptosis induced by 1-β-D-Arabinofuranosyl-cytosine and other DNA-damaging agents. Blood 88:1936-1943.
13. Ellis RE, Yuan J, Horvitz HR. 1991. Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663-698.
14. Enari M, Hug H, Nagata S. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78-81.
15. Enari M, Talanian RV, Wong WW, Nagata S. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723-726.
16. Faleiro L, Kobayashi R, Fearnhead H, Lazebnik Y. 1997. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J 16:2271-2281.
17. Frisch SM, Vuori K, Kelaita D, Sicks S. 1996. A role for Jun-N-terminal kinase in anoikis; Suppression by bcl-2 and crmA. J Cell Biol 135:1377-1382.
18. Gagliardini V, Fernandez P-A, Lee RKK, Drexler HCA, Rotello RJ, Fishman MC, Yuan J. 1994. Prevention of vertebrate neuronal death by the crmA gene. Science 263:826-828.
19. Greenberger JS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ. 1983a. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 80:2931-2935.
20. Greenberger JS, Eckner RJ, Sakakeeny M, Marks P, Reid D, Nabel G, Hapel A, Ihle JN, Humphries KC. 1983b. Interleukin 3-dependent hematopoietic progenitor cell lines. Fed Proc 42:2762-2771.
21. Hasegawa J-I, Kamada S, Kamiike W, Shimizu S, Imazu T, Matsuda H, Tsujimoto Y. 1996. Involvement of CPP32/ Yama(-like) proteases in Fas-mediated apoptosis. Cancer Res 56:1713-1718.
22. Jacobson MD, Weil M, Raff MC. 1996. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J Cell Biol 133:1041-1051.
23. Jacobson MD, Weil M, Raff MC. 1997. Programmed cell death in animal development. Cell 88:347-354.
24. Johnson DE. 1998. Regulation of survival pathways by IL-3 and induction of apoptosis after IL-3 withdrawal. Front Biosci 3:313-324.
25. Keane RW, Srinivasan A, Foster LM, Testa M-P, Ord T, Nonner D, Wang H-G, Reed JC, Bredesen DE, Kayalar C. 1997. Activation of CPP32 during apoptosis of neurons and astrocytes. J Neurosci Res 48:168-180.
26. Komiyama T, Ray CA, Pickup DJ, Howard AD, Thornberry NA, Peterson EP, Salvesen G. 1994. Inhibition of interleukin-1β converting enzyme by the cowpox virus serpin CrmA. J Biol Chem 269:19331-19337.
27. Krajewska M, Wang H-G, Krajewski S, Zapata JM, Shabaik A, Gascoyne R, Reed JC. 1997. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease. Canc Res 57:1605-1613.
28. Kuida K, Zheng TS, Na S, Kuan C-Y, Yang D, Karasuyama H, Rakic P, Flavell RA. 1996. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368-372.
29. Kumar S. 1995. Inhibition of apoptosis by the expression of antisense Nedd2. FEBS Lett 368:69-72.
30. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347.
31. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W, Schulze-Osthoff K. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375: 81-83.
32. Martin SJ, Bradley JG, Cotter TG. 1990. HL-60 cells induced to differentiate toward neutrophils subsequently die via apoptosis. Clin Exp Immunol 79:448-453.
33. Martins LM, Kottke T, Mesner PW, Basi GS, Sinha S, Frigon N Jr., Tatar E, Tung JS, Bryant K, Takahashi A, Svingen PA, Madden BJ, McCormick DJ, Earnshaw WC, Kaufmann SH. 1997. Activation of multiple interleukin-1β converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J Biol Chem 272:7421-7430.
34. Metcalf D.. 1989. The molecular control of blood forming cells. Nature 339:27-30.
35. Metcalf D. 1991. Control of granulocytes and macrophages: Molecular, cellular, clinical aspects. Science 254:529-533.
36. Miossec C, Dutilleul V, Fassy F, Diu-Hercend A. 1997. Evidence for CPP32 activation in the absence of apopto-sis during T lymphocyte stimulation. J Biol Chem 272: 13459-13462.
37. Nicholson DW. 1996. ICE/CED-3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nature Biotech 14:297-301.
38. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
39. Ohta T, Kinoshita T, Naito M, Nozaki T, Masutani M, Tsuruo T, Miyajima A. 1997. Requirement of the caspase-3/CPP32 protease cascade for apoptotic death after cytokine deprivation in hematopoietic cells. J Biol Chem 272:23111-23116.
40. Pickup, DJ, Ink BS, Hu W, Ray CA, Joklik WK. 1986. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc Natl Acad Sci USA 83:7698-7702.
41. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ. 1992. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69:597-604.
42. Rodriquez-Tarduchy G, Collins M, Lopez-Rivas A. 1990. Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J 9:2997-3002.
43. Salvesen GS, Dixit VM. 1997. Caspases: Intracellular signaling by proteolysis. Cell 91:443-446.
44. Sanz C, Benito A, Silva M, Abella B, Richard C, Segovia JC, Insunza A, Bueren JA, Fernandez-Luna JL. 1997. The expression of Bcl-X is downregulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage. Blood 89:3199-3204.
45. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. 1989. Macrophage phagocytosis of aging neutrophils in inflammation: Programmed cell death in the neutrophil leads to its recognition by macrophages.. J Clin Invest 83:865-875.
46. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin T-T, Nicholson DW. 1996. CPP32/apopain is a key interleukin 1β converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem 271:1841-1844.
47. Stefanis L, Park DS, Yan CYI, Farinelli SE, Troy CM, Shelanski ML, Greene LA. 1996. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support. J Biol Chem 271:30663-30671.
48. Takahashi A, Alnemri ES, Lazebnik YA, Fernandes-Alnemri T, Litwack G, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC. 1996. Cleavage of lamin A by Mch2α but not CPP32: Multiple interleukin 1β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA 93:8395-8400.
49. Tewari M and Dixit VM. 1995. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 270:3255-3260.
50. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. 1995. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose)polymerase. Cell 81:801-809.
51. Thompson, CB. 1995. Apoptosis in the pathogenisis and treatment of disease. Science 267:1456-1462.
52. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJ-F, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin T-T, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ. 1992. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356:768-774.
53. Thornberry NA, Peterson EP, Zhao JJ, Howard AD, Griffin PR, Chapman KT. 1994. Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones. Biochem 33:3934-3940.
54. Thornberry NA, Miller DK, Nicholson, DW. 1995. Interleukin-1β converting enzyme and related proteases as potential targets in inflammation and apoptosis. Persp Drug Discovery Design 2:389-399.
55. Wilhelm S, Wagner H, Hacker G. 1998. Activation of caspase-3-like enzymes in nonapoptotic T cells. Eur J Immunol 28:891-900.
56. Williams G, Smith C, Spooncer E, Dexter T, Taylor D. 1990. Haematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76-79.
57. Wyllie AH, Morris RG, Smith AL, Dunlop D. 1984. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67-77.
58. Zapata JM, Takahashi R, Salvesen GS, Reed JC. 1998. Granzyme release and caspase activation in activated human T-lymphocytes. J Biol Chem 273:6916-6920.